002693 Stock Overview
Hainan Shuangcheng Pharmaceuticals Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Hainan Shuangcheng Pharmaceuticals Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.15 |
| 52 Week High | CN¥20.20 |
| 52 Week Low | CN¥6.32 |
| Beta | 0.36 |
| 1 Month Change | -14.84% |
| 3 Month Change | -47.01% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -57.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002693 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 15.4% | 2.4% | -0.8% |
| 1Y | n/a | 7.1% | 9.6% |
Return vs Industry: Insufficient data to determine how 002693 performed against the CN Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 002693 performed against the CN Market.
Price Volatility
| 002693 volatility | |
|---|---|
| 002693 Average Weekly Movement | 13.6% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 4.3% |
Stable Share Price: 002693's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: Insufficient data to determine 002693's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 474 | Jianming Li | www.shuangchengmed.com |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Hainan Shuangcheng Pharmaceuticals Co., Ltd. Fundamentals Summary
| 002693 fundamental statistics | |
|---|---|
| Market cap | CN¥3.38b |
| Earnings (TTM) | -CN¥86.96m |
| Revenue (TTM) | CN¥180.64m |
Is 002693 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002693 income statement (TTM) | |
|---|---|
| Revenue | CN¥180.64m |
| Cost of Revenue | CN¥79.39m |
| Gross Profit | CN¥101.25m |
| Other Expenses | CN¥188.21m |
| Earnings | -CN¥86.96m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | 56.05% |
| Net Profit Margin | -48.14% |
| Debt/Equity Ratio | 44.9% |
How did 002693 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/23 13:08 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hainan Shuangcheng Pharmaceuticals Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jie Yao | Everbright Securities Co. Ltd. |
| Yun Li | Guodu Securities Co. |